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PRECLINICAL RESEARCH
ntagonism of Selectin
unction Attenuates Microvascular
latelet Deposition and Platelet-Mediated
yocardial Injury After Transient Ischemia
osé A. Barrabés, MD,* David Garcia-Dorado, MD, FACC,* Maribel Mirabet, PHD,* Javier Inserte, PHD,*
uis Agulló, PHD,* Bernat Soriano, PHARMD,† Anna Massaguer, PHD,‡ Ferran Padilla, MD,*
osa-Maria Lidón, MD,* Jordi Soler-Soler, MD, FACC*
arcelona, Spain
OBJECTIVES The goal of this study was to assess whether selectin blockade reduces myocardial platelet
deposition and platelet-mediated injury after transient ischemia.
BACKGROUND Selectins participate in platelet adhesion to reperfused endothelium.
METHODS Thiopental-anesthetized, open-chest pigs were subjected to mechanical injury of the left anterior
descending coronary artery followed by a 48-min occlusion and 2 (n  20) or 4 (n  16) h of
reperfusion. Fifteen minutes before occlusion, animals were blindly allocated to receive a
continuous intravenous infusion of the selectin blocker fucoidan (30 g/kg/min, plus a 1-mg/kg
bolus in the latter group) or saline. In isolated rat hearts infused with thrombin-activated platelets,
the effects of fucoidan (30 g/ml) administered during reperfusion after 40 min of global ischemia
were also analyzed.
RESULTS Fucoidan did not prevent the development of cyclic reductions in coronary flow, but reduced the
content of 99mTc-labeled platelets in reperfused myocardium after 2 h of reperfusion (23.4 3.3
vs. 42.1  8.3  106 platelets/g in treated and untreated animals, p  0.03) and attenuated the
impairment in the coronary flow reserve and reduced infarct size after 4 h (53 2% vs. 73 5%
of the ischemic region, respectively, p  0.003). Treated animals showed a trend toward less
neutrophil infiltration early after reperfusion, but not after 4 h. In isolated hearts, fucoidan
improved functional recovery and reduced coronary resistance and lactate dehydrogenase release,
lacking any beneficial effects if given in the absence of platelets.
CONCLUSIONS The results suggest that selectin-dependent adhesion is a prominent mechanism of platelet
deposition in reperfused cardiac microvessels and highlight its potential as a therapeutic target
in patients with acute myocardial infarction. (J Am Coll Cardiol 2005;45:293–9) © 2005 by
ublished by Elsevier Inc. doi:10.1016/j.jacc.2004.09.068the American College of Cardiology Foundation
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she beneficial effects of prompt restoration of coronary flow
n patients with acute myocardial infarction may be limited
y insufficient tissue perfusion. Among the factors contrib-
ting to this phenomenon (1), platelets deposited in capil-
aries and venules likely play a prominent role. Supporting
his, platelets accumulate preferentially in the most dam-
ged areas of reperfused myocardium (2–5), and studies
ddressing the effect of these cells after transient ischemia
ave shown, with some exceptions (6,7), that platelets may
inder blood flow and contractile recovery or increase
yocardial injury (8–11).
The mechanisms of platelet deposition in reperfused
oronary microvessels are incompletely understood and
ikely involve both a direct adhesion to the endothelium and
inding to adherent leukocytes (12). Interactions between
From the Departments of *Cardiologı´a and †Medicina Nuclear, Hospital Univer-
itari Vall d’Hebron, Barcelona, Spain; and ‡Immunology Unit, IDIBAPS, Barce-
ona, Spain. Supported by grants from the Fondo de Investigación Sanitaria
FIS02/0660), Spanish Society of Cardiology (Beca 2002), Fundació Marató TV3
4310/2000), and RECAVA.b
Manuscript received July 13, 2004; revised manuscript received September 23,
004, accepted September 28, 2004.ndothelial intracellular adhesion molecule-1 and platelet
lycoprotein (GP) IIb/IIIa and between P-selectin ex-
ressed on platelets or endothelial cells and their corre-
ponding ligands have been demonstrated after intestinal
13,14), hepatic (15), or cerebral (16) ischemia, but their
eight in the heart remains unclear. In this respect, whether
P IIb/IIIa blockade reduces microvascular platelet depo-
ition or myocardial injury after reperfusion independent of
ts effects on the culprit lesion is controversial (5,17–19). On
he other hand, interfering with P-selectin function has long
een proposed as a strategy to reduce neutrophil infiltration
nd subsequent myocardial damage after reperfusion (20–
3), but the effects of this approach on microvascular
latelet adhesion are unknown.
Accordingly, we aimed to investigate whether selectin
lockade reduces microvascular platelet deposition and
latelet-mediated myocardial injury after transient ischemia.
xperiments were conducted in anesthetized pigs and in
solated rat hearts receiving or not receiving fucoidan, a
ulfated polysaccharide that binds P- and L-selectin and has
een extensively used as a selectin blocker (22–24).
MA
a
A
1
1
p
i
l
i
p
i
m
v
S
c

t
r
a
i
w
c
w
w
d
B
1
a
a
d
A
v
S
b
d
l
P
a
w
M
g
p
r
t
t
o
a
1
c
R
m
i
fl
e
I
h
a
z
(
i
s
d
a
t
O
h
J
f
E
i
d
T
E
L
P
M
P
A
V
294 Barrabés et al. JACC Vol. 45, No. 2, 2005
Selectin Blockade and Platelet-Mediated Injury January 18, 2005:293–9ETHODS
nimal preparation. After obtaining institutional approval,
nd in accordance with the position of the American Heart
ssociation on research animal use adopted in November
984, 49 pigs of either gender (35  1 kg) were sedated with
0-mg/kg intramuscular azaperone, anesthetized with thio-
ental (10-mg/kg intravenous bolus and continuous infusion),
ntubated, and ventilated with room air. After sternotomy, the
eft anterior descending coronary artery (LAD) was dissected
n its midsegment and surrounded by a snare. A Doppler flow
robe (Transonic Systems, Ithaca, New York) was placed
mmediately distal to the snare, and a Millar (Houston, Texas)
icromanometer-tipped catheter advanced into the left
entricle.
tudy protocol. Animals were randomly and blindly allo-
ated to receive a continuous intravenous infusion of 30
g/kg/min fucoidan (Sigma, St. Louis, Missouri)—a dose
hat has reduced neutrophil adhesion and infarct size after
eperfusion in vivo (23)—or isotonic saline. Fifteen minutes
fter start of the infusion, the LAD was injured with an
ntracoronary catheter as described (4,5). Then, the snare
as tightened for 48 min, an occlusion period usually
ausing incomplete infarctions in this model (4,25), after
hich reperfusion was allowed. Two series of experiments
ere performed: series A was destined to quantify myocar-
ial platelet deposition 2 h after reperfusion, and series
—in which animals allocated to fucoidan also received a
-mg/kg bolus—to assess infarct size 4 h after reperfusion.
A total of four animals were excluded due to left main
rtery occlusion or to refractory ventricular fibrillation (VF),
nd nine (four receiving fucoidan and five vehicle, p  NS)
ue to LAD reocclusion. A total of 20 experiments in series
able 1. Hematologic Parameters and Results of Coagulation As
Series A
Fucoidan (n  10) Ve
Initial Final Initi
rythrocytes,  106/l 4.3  0.3 4.2 0.2 4.6 
eukocytes,  103/l 15.2  1.1 10.5 1.1 17.9 
latelets,  103/l 442  20 358 21* 447 
ean platelet volume, fl 7.7  0.3 7.5 0.3 7.6 
rothrombin time, % 111  3 111 2 109 
ctivated partial thromboplastin
time, s
24  2 25 2 23 
Abbreviations and Acronyms
CFR  cyclic flow reduction
GP  glycoprotein
LAD  left anterior descending coronary artery
LDH  lactate dehydrogenase
LVEDP  left ventricular end-diastolic pressure
MPO  myeloperoxidase
VF  ventricular fibrillationalues are mean  SEM. *p  0.001 for the effect of treatment.(10 per group) and 16 in series B (8 per group) remained
alid.
tudy monitoring. Hematologic determinations and
leeding time were serially measured (5). One electrocar-
iographic lead, aortic pressure, coronary blood flow, and
eft ventricular pressure were amplified, digitized (ML795-
owerLab, AD Instruments, Mountain View, California),
nd recorded. When VF occurred, 10 to 20 J internal shocks
ere applied.
yocardial platelet content. The previous day, autolo-
ous platelets were labeled with 99mTc-hexamethyl-
ropyleneamineoxime as described (4,5) and immediately
einjected in animals from series A. After excising the heart,
he aortic root was perfused (4) to wash the coronary vascula-
ure, and the heart sliced. The radioactivity of fragments
btained from the reperfused anteroseptal region (2.9 0.1 g)
nd from the inferior region (3.8  0.2 g), along with that of
-ml blood, was counted, and myocardial platelet content
alculated as described previously (4,5).
eactive hyperemic response. At baseline, 15, 60, and 180
in after reperfusion, the LAD was occluded for 25 s
mmediately proximal to the occlusion site in series B. Peak
ow was the maximum mean flow after these occlusions,
xpressed as a percentage of the respective baseline values.
nfarct size and neutrophil infiltration. In series B, the
eart was excised 4 h after reperfusion and sliced. The area
t risk (in vivo fluorescein) and infarct size (triphenyltetra-
olium chloride reaction) were calculated as described
4,5,25).
Myeloperoxidase (MPO) activity, an index of neutrophil
nfiltration, was determined as described earlier (4,5) in
amples (1.3  0.1 g) from reperfused and control myocar-
ium. Myeloperoxidase activity was also analyzed in eight
dditional pigs allocated to fucoidan or vehicle and receiving
he same protocol as in series A, but only 1 h of reperfusion.
ne slice was processed for histologic analysis, stained with
ematoxylin-eosin, and examined with an Olympus (Tokyo,
apan) IMT2 microscope. Neutrophil infiltration was scored
rom 0 to 3 as previously described (5).
xperiments in isolated rat hearts. Porcine platelets were
solated and resuspended in modified Tyrode buffer as
escribed earlier (11). After activation with 0.1-U/ml hu-
Series B
(n  10) Fucoidan (n  8) Vehicle (n  8)
Final Initial Final Initial Final
5.0  0.1 4.7  0.1 4.8 0.2 5.1  0.1 5.4  0.2
15.6  1.2 16.8  0.7 15.6 1.6 16.6  1.2 18.4  1.7
445  39 512  26 371 18* 481 47 443  46
7.6  0.3 8.2  0.4 8.2 0.5 7.8  0.4 7.7  0.3
115  8 110  2 106 2 112  1 109  2
23  1 19  1 21 1 19  1 20  1says
hicle
al
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January 18, 2005:293–9 Selectin Blockade and Platelet-Mediated Injuryan thrombin, platelets were treated or not treated with
0-g/ml fucoidan—a concentration that has preserved
entricular function in blood-reperfused isolated hearts
22)—for 5 min at 37°C (final concentration, 4  1010
latelets/l). We previously assessed that platelet incubation
ith this concentration of thrombin induces a marked
ncrease in P-selectin expression but not aggregation (11),
hich is unaffected by subsequent incubation with fucoidan.
Hearts from pentobarbital-anesthetized male Sprague-
awley rats (n 16) were placed in a Langerdoff apparatus,
erfused at 10 ml/min with modified Krebs-Henseleit
icarbonate buffer (11,25). After equilibration, hearts were
ubjected to 40 min of no-flow ischemia followed by 60 min
f reperfusion. Thrombin-activated platelets were infused
nto the coronary flow at a constant rate of 0.5 ml/min.
earts were infused with 108 untreated platelets during the
ast 5 min of equilibration and with 108 platelets, treated or
ot treated with fucoidan, during the first 5 min of
eperfusion. Eight additional hearts subjected to the same
rotocol received or did not receive fucoidan for 5 min
efore ischemia in the absence of platelets. Left ventricular
nd-diastolic pressure (LVEDP), developed pressure, per-
usion pressure, and lactate dehydrogenase (LDH) release
ere measured (11,25).
tatistical analysis. Statistical analysis was performed us-
ng SPSS software. Values are expressed as mean  SEM.
aired t tests and repeated measures analysis of variance
ere used to assess changes in physiologic parameters and
heir modification by treatment as well as differences be-
ween reperfused and control myocardium within the same
nimal. Independent, prespecified intergroup comparisons
ere performed by Student t tests, with the exception of
hose involving histologic scores, which were subjected
o the Mann-Whitney U test. Values of p  0.05 were
onsidered significant.
ESULTS
ematologic determinations and bleeding time. Blood
ell counts and coagulation parameters experienced minor
hanges and were unaffected by treatment allocation, with
he exception of platelet count, which was reduced by about
0% by fucoidan (Table 1). Bleeding time increased slightly
n controls and showed a rapid and sustained prolongation
fter start of fucoidan (Fig. 1).
emodynamic data, ventricular arrhythmias, and coro-
ary blood flow. Heart rate and mean aortic pressure were
ithin the normal range at baseline and increased (p  0.01)
uring the experiment (Table 2). Left ventricular end-diastolic
ressure increased after coronary occlusion (p  0.01) and
emained stable thereafter, without between-group differences.
reated and untreated animals had a similar incidence of VF
uring coronary occlusion (22% in both arms) and immediately
fter reperfusion (33% vs. 39%, p  NS). Baseline blood flow
t the LAD averaged 16  2 ml/min. The total number of
yclic flow reductions (CFRs) during the reperfusion period in greated and untreated animals was, respectively, 6  2 versus
1  2 in series A and 6  2 versus 14  6 in series B (p 
.089 for comparison between both arms in pooled data).
pproximately one-half of CFRs occurred during the first
our of reperfusion.
yocardial platelet content. Platelet content averaged
2.5  1.1  106/g in the control zone, without intergroup
ifferences, and 32.7  4.8  106/g in the reperfused zone
p  0.001 with respect to the value in the control region).
latelet deposition in the reperfused zone did not correlate
ith the number of CFRs (r  0.14) and was significantly
educed by fucoidan (Fig. 2).
eactive hyperemic response. At baseline, peak hyper-
mic response after a brief LAD occlusion was 206  21%
f the preocclusion value in animals allocated to fucoidan
nd 279  41% in controls (p  0.14). The hyperemic
esponse was severely blunted in both groups after reperfu-
ion, but treated animals had a significantly better recovery
f microvascular function (Fig. 3).
nfarct size and neutrophil infiltration. The area at risk
veraged 8.4  0.9% of biventricular mass in animals
eceiving fucoidan and 9.2  1.5% in controls (p  NS).
nfarct size was significantly reduced by fucoidan (53  2%
f the ischemic region vs. 73  5% in controls, p  0.003).
In all series, MPO activity values in reperfused myocar-
ium were significantly higher than in the control zone
Table 3). There was a trend toward less MPO activity in
eperfused myocardium in animals receiving fucoidan after 1
p 0.18) and 2 (p 0.2) h of reperfusion, especially in the
ubepicardial zone. At 4 h, the values were much higher and
omparable in both groups. Histologic scores for neutrophil
nfiltration in treated and untreated animals were, respec-
ively, 0.5  0.3 versus 1.4  0.2 in series A (p  0.04) and
.3  0.4 versus 1.7  0.5 in series B (p  NS). Only two
rteriolar microemboli were seen, in one treated animal
rom series B.
tudies in isolated rat hearts. The absence of microaggre-
igure 1. Bleeding time in series A (circles) and B (inverted triangles). p
alue: effect of fucoidan (repeated measures analysis of variance).ates in the platelet suspensions was assessed by flow
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Selectin Blockade and Platelet-Mediated Injury January 18, 2005:293–9ytometry. Compared with hearts infused with untreated
ctivated platelets, those receiving fucoidan during the initial
inutes of reperfusion had similar hypercontracture, as as-
essed by the early peak in LVEDP, but showed improved
ontractile recovery as well as reduced coronary resistance (Fig.
) and released less LDH (51  8 vs. 81  6 U/gdw, p 
.008) throughout the reperfusion period (Fig. 5). If adminis-
ered in the absence of platelets, fucoidan lacked any beneficial
ffects on these functional parameters or on LDH release (81
5 vs. 79  6 U/gdw, respectively, p  NS).
ISCUSSION
n the present study, selectin antagonism with fucoidan in a
odel of transient, thrombotic coronary occlusion in swine
mproved the coronary flow reserve and reduced the mag-
itude of platelet deposition and the extent of necrosis in
eperfused myocardium, with these effects being paralleled
y a diminished neutrophil infiltration only early after
able 2. Hemodynamic Data
Before CO 15 min C
eries A (n  10 per group)
Heart rate, beats/min
Vehicle 76  10 76  9
Fucoidan 80  5 82  5
Mean aortic pressure, mm Hg
Vehicle 98  6 97  6
Fucoidan 94  5 94  5
LVEDP, mm Hg
Vehicle 8  1 14 3
Fucoidan 6  2 13 2
eries B (n  8 per group)
Heart rate, beats/min
Vehicle 83  7 88  8
Fucoidan 97  5 96  5
Mean aortic pressure, mm Hg
Vehicle 81  8 78  8
Fucoidan 70  3 71  3
LVEDP, mm Hg
Vehicle 6  1 14 4
Fucoidan 8  1 16 2
alues are mean  SEM. No significant intergroup differences were observed.
CO  coronary occlusion; LVEDP  left ventricular end-diastolic pressure; R Figure 2. Myocardial platelet content after 2 h of reperfusion.
F
aeflow. Fucoidan was also protective when administered
fter global ischemia in isolated rat hearts infused with
ctivated platelets, but not if given before ischemia without
latelets.
latelet deposition in coronary microvasculature and
eperfusion injury. Because platelets participate in the
no-reflow” phenomenon (1–5,8–11), attempts have been
ade to increase myocardial salvage after reperfusion by
nhibiting platelet function. Cyclooxygenase inhibitors have
ailed to attenuate myocardial platelet accumulation (2–4),
nd studies have differed on the effects of GP IIb/IIIa
lockers on microvascular function after reperfusion (17,18).
ecently in our laboratory, GP IIb/IIIa blockade stabilized
he culprit lesion but did not reduce microvascular platelet
ccumulation or infarct size after transient coronary occlu-
48 min CO 30 min R 2 h R 4 h R
79  10 86  8 86  8 —
83  4 88  4 87  4 —
101  5 103  5 106  7 —
95  5 99  5 103  5 —
15  4 13  3 14  2 —
11  1 16  4 15  3 —
93  9 100 8 101  9 110  9
94  7 96  7 102  6 115  4
83  8 84  8 89  7 85  8
69  2 73  3 80  3 81  4
16  5 19  4 14  4 9  2
16  4 20  3 10  3 13  3
rfusion.Oigure 3. Peak hyperemic response at the left anterior descending coronary
rtery. p value: effect of fucoidan (repeated measures analysis of variance).
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January 18, 2005:293–9 Selectin Blockade and Platelet-Mediated Injuryion in swine (5) nor protect against platelet-mediated
njury in isolated reperfused rat hearts (11). Not at variance
ith these results, the main benefit of these agents in
atients with acute myocardial infarction receiving reperfu-
ion therapy has been a reduced incidence of recurrent
schemic events (26).
In the present study, the selectin-binding polysaccharide
ucoidan, at doses inhibiting selectin function and lacking
able 3. Myeloperoxidase Activity (IU/g) in Myocardial Samples
r 4 h of Reperfusion in Swine
Time After
Reperfusion
Control Zone Subendocardial R
Vehicle Fucoidan Vehicle Fu
h (n  8) 0.15  0.05 0.04  0.02 0.57  0.17 0.4
h (n  20) 0.14  0.05 0.11  0.02 —
h (n  16) 0.43  0.20 0.33  0.25 3.02  1.13 3.0
alues are mean  SEM. Separate sampling from the subendocardial and subepicar
ntergroup differences were observed.
igure 4. Left ventricular end-diastolic pressure (LVEDP), developed
ressure (LVdevP), and perfusion pressure (PP) throughout the experi-
ents in isolated rat hearts. P value: effect of fucoidan (repeated measuresnalysis of variance). Solid circles  control (n  8); open circles 
ucoidan (n  8).
i
vnticoagulant effects (22–24), prolonged bleeding time but
ad a modest effect on the thrombus burden at the epicar-
ial artery, as it did not reduce reocclusion rate and lessened
he number of CFRs by only one-half. However, fucoidan
ignificantly attenuated microvascular platelet deposition
nd myocardial injury.
Fucoidan not being a specific P-selectin antagonist, it is
ot possible to ascertain to what extent its effects on platelet
eposition were due to the inhibition of a direct, P-selectin-
ediated interaction between platelets and endothelial cells
14–16) or to a reduced leukocyte recruitment—by antag-
nizing P- and L-selectin—and subsequent platelet binding
o adherent leukocytes (12). The small effect of fucoidan on
PO activity and its protective effect in isolated hearts
erfused without leukocytes suggest that the role of
ndothelium-dependent platelet adhesion is significant.
Our results also stress the importance of activation status
n determining the influence of platelets on reperfused
yocardium (11), which could help explain the discrepancy
n results of previous studies (7–10). The lack of correlation
etween myocardial platelet content and the number of
FRs, and the paucity of microemboli found at histologic
nalysis concur with previous observations (4,5) indicating
hat spontaneous microembolization in this model is rare
nd suggest that the protective effects of fucoidan were
ndependent of this phenomenon.
nvolvement of neutrophils. Treatment with fucoidan
as associated with a reduced neutrophil infiltration in the
r Coronary Injury Followed by 48 min of Occlusion and 1, 2,
Reperfused Zone
Subepicardial Region Overall
an Vehicle Fucoidan Vehicle Fucoidan
.20 0.39  0.18 0.14  0.04 0.48  0.14 0.31  0.12
— — 0.25  0.06 0.15  0.04
.77 1.76  0.59 1.94  0.42 2.39  0.77 2.48  0.53
nes within the ischemic region was not performed in the 2-h group. No significant
igure 5. Lactate dehydrogenase (LDH) release after reperfusion inAfte
egion
coid
8  0
—
1  0solated hearts. P value: effect of fucoidan (repeated measures analysis of
ariance).
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Selectin Blockade and Platelet-Mediated Injury January 18, 2005:293–9rea at risk early after reflow, especially in the subepicardial
egion, but not at 4 h. This is consistent with a predominant
nvolvement of selectins in the early inflammatory response,
hich may be perpetuated later on by alternative mecha-
isms (27). Significant neutrophil infiltration in reperfused
issues despite selectin inhibition has been reported previ-
usly (19,23).
Although not always successfully (28), selectin antago-
ists have long been used to reduce neutrophil recruitment
nd subsequent myocardial damage after ischemia (20–23).
n addition, platelets and neutrophils act synergistically, by
mechanism involving P-selectin, in provoking postisch-
mic cardiac dysfunction (10). Accordingly, it is possible
hat part of the benefit of fucoidan in our experiments in
wine was mediated by an effect on neutrophils. Although
eutrophil infiltration was comparable in both groups 4 h
fter reperfusion, toxic substances causing myocardial injury
ight have been released by intravascular neutrophils in the
arlier phases (27). However, the results of the experiments
n isolated hearts indicate that part of the protective effect of
ucoidan was independent of neutrophils and was platelet-
ediated.
ethodologic considerations and limitations. The de-
rease in blood platelet count after fucoidan administration
oncurs with previous reports (29). Because fucoidan does
ot affect platelet P-selectin expression in vitro (data not
hown) nor mean platelet volume, it is unlikely that this
henomenon was caused by an enhanced activation or by
he formation of platelet aggregates.
Platelet content in the control region in series A seems
igh. This could have been due to some activation during
he experimental protocol (11) or occurring postmortem.
owever, if this background activity had been lower, the
eduction in the estimated platelet content with fucoidan
ould probably have been greater. In series B, the size of the
rea at risk was somewhat smaller than in previous studies in
he same model (5,25). However, infarcts (as a percentage of
he ischemic zone) were relatively large, making it difficult
hat the results would have been different with a more
roximal occlusion. Although myocardial perfusion was not
irectly measured, microvascular function was indirectly
ssessed in both models.
Fucoidan could have not been so beneficial in swine if
dministered only during the reperfusion period. However,
he results of the experiments in isolated hearts, along with
revious reports of a protective effect of P-selectin antago-
ism during reperfusion (20–23), suggest that it acted
ainly in this period. Finally, it cannot be completely
xcluded that fucoidan had worked, in part, through mech-
nisms other than interacting with selectins, although its
ack of effect when given alone and the fact that it did not
nfluence hemodynamics, coagulation parameters, or plate-
et activation status work against this possibility.
linical implications. Improving myocardial perfusion is
rucial in the management of patients with acute myocardial
nfarction. The present study highlights the deleteriousnfluence of activated platelets and suggests that selectins
ontribute significantly to platelet deposition in reperfused
oronary microvessels. Moreover, the results suggest that
art of the protective effect of antagonizing these adhesion
olecules described previously (20–23) might have been
latelet-mediated and stress the role of selectin-mediated
latelet adhesion as a potential therapeutic target. However,
s the encouraging results of strategies blocking other cell
dhesion receptors in animal studies have apparently not
een paralleled by a reduction in infarct size in patients with
cute myocardial infarction (27,30), the potential clinical
enefit of inhibition of selectin-mediated platelet adhesion
as yet to be proved.
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